Anzeige
Mehr »
Login
Dienstag, 15.04.2025 Börsentäglich über 12.000 News von 690 internationalen Medien
Global Tactical tritt dem Critical Minerals Institute bei!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 29.11.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
29.11.24Nasdaq Stockholm AB: Delisting of Metabolic Nordic AB from Nasdaq First North Growth Market82Today, on November 29, 2024, Metabolic Nordic AB was declared bankrupt by Malmö District Court. According to item 8.2.7 of the Nasdaq First North Growth Market Rulebook, the exchange may decide...
► Artikel lesen
29.11.24Nasdaq Stockholm AB: Delisting of Newlist AB (publ) from Nasdaq First North Growth Market170On 28 November 2024, Newlist AB (publ) was declared bankrupt by the Västmanland District Court. According to item 8.2.7 of the Nasdaq First North Growth Market Rulebook, the exchange may decide...
► Artikel lesen
29.11.24Nimbus Group AB: Bulletin from the Extraordinary General Meeting in Nimbus Group AB (publ)149Today, on 29 November 2024, an Extraordinary General Meeting in Nimbus Group AB (publ) ("Nimbus Group" or the "Company") was held. The general meeting resolved on subsequent approval of the board of...
► Artikel lesen
29.11.24Mainz BioMed NV: Mainz Biomed Announces Stock Split1.234BERKELEY, Calif. and MAINZ, Germany, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the...
► Artikel lesen
29.11.24Investec Bank PLC: Half-year Report23Investec Bank plcIncorporated in England and WalesRegistration number 489604LEI: 84S0VF8TSMH0T6D4K848 Unaudited condensed Financial Statements...
► Artikel lesen
29.11.24Abliva AB: Abliva AB Interim Report January - September 2024162- Positive Interim Analysis of the FALCON Study Paves the Way for KL1333 Development - Third Quarter SummaryImportant events July - September 2024In July, Abliva announced a positive outcome of the...
► Artikel lesen
29.11.24Patagonia Gold Corp.: Patagonia Gold Third Quarter 2024 Financial Results150VANCOUVER, British Columbia, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Patagonia Gold Corp. ("Patagonia" or the "Company") (TSXV: PGDC) announces its financial results for the quarter ended September 30,...
► Artikel lesen
29.11.24Premier American Uranium Inc: Premier American Uranium Announces Management Change188TORONTO, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Premier American Uranium Inc. ("PUR", the "Company" or "Premier") (TSXV: PUR) (OTCQB: PAUIF) announces that David Suda, President of the Company, has resigned...
► Artikel lesen
29.11.24Halmont Properties Corporation Third Quarter Results176TORONTO, Nov. 29, 2024 (GLOBE NEWSWIRE) -- HALMONT PROPERTIES CORPORATION (TSX-V: HMT) ("Halmont" or the "Company") announced today that net income to shareholders for the nine months ended September...
► Artikel lesen
29.11.24Cue Biopharma, Inc.: Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)218BOSTON, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage...
► Artikel lesen
29.11.24Red White & Bloom Brands Inc.: Red White & Bloom Reports Third Quarter 2024 Financial Results8302024-YTD EBITDA increased to $7.5 million; a twenty-fold improvement compared to 2023-YTD EBITDA of $0.4 million2024-YTD Adjusted EBITDA increased 260% to $9.6 million compared to 2023-YTD of $3.7...
► Artikel lesen
29.11.24TransCode Therapeutics, Inc.: TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split315BOSTON, Nov. 29, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) ("TransCode" or the "Company"), the RNA Oncology Company committed to more effectively treating cancer using RNA...
► Artikel lesen
29.11.24Future Vision II Acquisition Corp. Announces Entering into Merger Agreement with Viwo Technology Inc.694NEW YORK, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Future Vision II Acquisition Corp., (NASDAQ: FVNNU) a publicly traded special purpose acquisition company (the "Future Vision") and Viwo Technology Inc....
► Artikel lesen
29.11.24Globus Maritime Limited Reports Financial Results for the Third Quarter and Nine-month period ended September 30, 2024183GLYFADA, Greece, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Globus Maritime Limited ("Globus", the "Company", "we", or "our") (NASDAQ: GLBS), a dry bulk shipping company, today reported its unaudited consolidated...
► Artikel lesen
29.11.24Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)279 BOSTON, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on November 29,...
► Artikel lesen
29.11.24Atlantic Petroleum P/F: Condensed Consolidated Interim Report - 3rd Quarter 2024348Tórshavn, Faroe Islands, 2024-11-29(GLOBE NEWSWIRE) -- P/F Atlantic Petroleum (NASDAQ Copenhagen: ATLA DKK) today posts its 3rd quarter results for 2024. This announcement should be read in conjunction...
► Artikel lesen
29.11.24Interoil Exploration & Production ASA: Report for the third quarter 2024351November 29, 2024Highlights in the period Interoil's total operated production for the first nine months of 2024 was 551,140 barrels of oil equivalent (boe), a decrease from 698,659 boe in the same...
► Artikel lesen
29.11.24Mars Acquisition Corp. Announces Adjournment of Extraordinary General Meeting and Extension of Redemption Deadline427NEW YORK, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Mars Acquisition Corp. (the "Company" or "Mars") (Nasdaq: MARX), a special purpose acquisition company, today announced that the extraordinary general meeting...
► Artikel lesen
29.11.2489bio, Inc.: 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)136SAN FRANCISCO, Nov. 29, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the "Company" or "89bio") (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization...
► Artikel lesen
29.11.24Valoe Oyj: Valoe Corporation Business Review January - September 2024293Valoe Oyj Business review 29 November 2024 at 20.20 THE THIRD QUARTER OF 2024 IN BRIEF Financial situation In July-September 2024,...
► Artikel lesen
Seite:  Weiter >>